Provided by Tiger Trade Technology Pte. Ltd.

BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS

366.73
-5.7600-1.55%
Pre-market: 359.93-6.8000-1.85%07:07 EDT
Volume:341.59K
Turnover:125.25M
Market Cap:41.81B
PE:65.61
High:372.00
Open:369.13
Low:364.73
Close:372.49
52wk High:385.22
52wk Low:253.95
Shares:114.00M
Float Shares:85.69M
Volume Ratio:1.26
T/O Rate:0.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.59
EPS(LYR):2.47
ROE:14.66%
ROA:7.46%
PB:8.08
PE(LYR):148.47

Loading ...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Cencora (COR), American Well (AMWL) and BeOne Medicines (ONC)

TIPRANKS
·
Aug 05

Major A-Share Developments: Beone Medicines Reports 627% Surge in First-Half Profit

Stock News
·
Aug 05

Beone Medicines Ltd. Increases 2026 Revenue Forecast to Between 44.9 Billion and 46.2 Billion Yuan

Stock News
·
Aug 05

BeOne Medicines AG Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Beone Medicines Reports Record Q2 Revenue Surge and Skyrocketing Profits, Revises 2026 Full-Year Guidance Higher

Deep News
·
Aug 05

Beone Medicines Reports Record First Half Results with Adjusted Net Income Surge of 111%

Stock News
·
Aug 05

GUIDANCE: (ONC) BeOne Medicines Expects 2026 Revenue Range $6.6B to $6.8B, vs. FactSet Est of $6.51B

MT Newswires Live
·
Aug 05

BeOne Medicines AG Expected to Post Earnings of $1.58 a Share - Earnings Preview

Reuters
·
Aug 03

Is BeOne Medicines (ONC) Stock Priced For Perfection On Earnings?

Simply Wall St.
·
Jul 30

Beigene Issues 866,100 New Shares Under Employee Stock Purchase Plan

Stock News
·
Jul 30

BeOne Medicines Targets Esophageal Cancer With New Tislelizumab Trial in Japan

TIPRANKS
·
Jul 30

Earning Preview: BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS revenue is expected to increase by 29%, and institutional views are bullish

Earnings Agent
·
Jul 29

Hong Kong Stock Market Analysis: ChangXin IPO Pressure Weighs, Agricultural Inflation Risks Boost Related Stocks

Stock News
·
Jul 24

BeiGene Invests Additional $300 Million in US Expansion, Stock Hits 3-Month High; Hong Kong Stock Connect Innovative Drugs Show Local Strength, 520880 Rises for Third Consecutive Day Against Market

Deep News
·
Jul 24

BeOne Medicines to Invest $300 Million to Expand US Drug Manufacturing

MT Newswires Live
·
Jul 23

Amgen and BeiGene Advance Subcutaneous Formulation of FIC Bispecific Antibody into Phase III Trial

Deep News
·
Jul 23

3 U.S. Drug Manufacturing Stocks Investors Are Watching As Tariffs Rise

Simply Wall St.
·
Jul 22

Press Release: Beone Medicines to Announce Second Quarter 2026 Financial Results on August 5

Dow Jones
·
Jul 17

BeOne Medicines (ONC) Stock Looks Expensive Even With Strong Pipeline Hopes

Simply Wall St.
·
Jul 16

How Chemotherapy-Free Phase 3 MCL Success At BeOne Medicines (ONC) Has Changed Its Investment Story

Simply Wall St.
·
Jul 15